Omu AE, Dashti H, Al-Othman S
What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have
Timing can vary depending on the severity of symptoms, the underlying cause, diet, medications, stress levels, and whether the gut issue is inflammatory, infectious, structural, or functional
Extracellular Matrix and Tissue Architecture Models GHK-Cu has been widely studied in laboratory systems for its potential influence on extracellular matrix components, including collagen, elastin, and glycosaminoglycans